Reagent for the typing of the DRB site of Levercode human leukocyte antigen - Taiwan Registration 8bf3c3c7314243f8bb7a801da3f73acc
Access comprehensive regulatory information for Reagent for the typing of the DRB site of Levercode human leukocyte antigen in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8bf3c3c7314243f8bb7a801da3f73acc and manufactured by GEN-PROBE TRANSPLANT DIAGNOSTICS, INC.. The authorized representative in Taiwan is METEK LAB INC..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including GEN-PROBE TRANSPLANT DIAGNOSTICS, INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Polymerase chain reaction (PCR) was used to detect the dual genotyping of human leukocyte antigen DRB and used with a Luminex fluorescence analyzer.
B Hematology, pathology, and genetics
B.0001 Human leukocyte antigen typing test system
import
Dates and Status
Jan 03, 2013
Jan 03, 2018
Jul 21, 2016
Cancellation Information
Logged out
่ช่ซ่จป้ท